Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PERRIGO R AND D

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 38
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 39
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

PERRIGO R AND D

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 42
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

ZYDUS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 37
  • 0 comments

FDA approve CHLORPROMAZINE HYDROCHLORIDE

Comment Full text

PRINSTON INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 38
  • 0 comments

FDA approve QUETIAPINE FUMARATE

Comment Full text

PAI HOLDINGS PHARM

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve VANCOMYCIN HYDROCHLORIDE

Comment Full text

L PERRIGO CO

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 47
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

IPSEN INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 38
  • 0 comments

FDA approve MECASERMIN RECOMBINANT

Comment Full text

L PERRIGO CO

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 39
  • 0 comments

FDA approve NICOTINE POLACRILEX

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve SUNITINIB MALATE

Comment Full text
  • Previous
  • 504
  • 505
  • 506
  • 507
  • 508
  • Next

Search

News categories

  • Technical Exchange News(13021)
  • Event(6229)
  • SEC News(322597)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(181732)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin